Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

Journal of Clinical Virology

Volumn 48, Issue SUPPL 1, 2010, Pages

  Gershon, Anne A ^a   Gershon, Michael D ^b   Breuer, Judith ^c   Levin, Myron J ^d   Oaklander, Anne Louise ^e   Griffiths, Paul D ^f  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c Centre for Infectious Disease   (United Kingdom)

^d UNIVERSITY OF COLORADO   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Epidemiology; Pathogenesis; VZV; Zoster

Indexed keywords

CHICKENPOX VACCINE;

ABDOMINAL DISEASE; AGE DISTRIBUTION; ARTICLE; CELLULAR IMMUNITY; CHICKENPOX; ETHNIC DIFFERENCE; EYE DISEASE; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; MOLECULAR EPIDEMIOLOGY; MORBIDITY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SENSORY NERVE; SKIN DISEASE; SPINAL GANGLION; VARICELLA ZOSTER VIRUS; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS TRANSMISSION;

AGED; AGED, 80 AND OVER; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; MALE; RISK FACTORS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 77952561045     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(10)70002-0     Document Type: Article

References (52)

1. Jako G.J., and Jako R.A. Short historical note: connection between varicella and herpes zoster. J Med 17 (1986) 267-269
2. von Bokay J. Uber den aetiologischen zusammenhang der varizellen mit gewissen fallen von herpes zoster. Wien Klin Wochenschr 22 (1909) 1323-1326
3. Straus S.E., Reinhold W., Smith H.A., Ruyechan W.T., Henderson D.K., Blaese R.M., et al. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med 311 (1984) 1362-1364
4. Weller T.H., and Stoddard M.B. Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid. J Immunol 68 (1952) 311-319
5. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 10 (1996) 571-581
6. Vázquez M. Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine. Curr Opin Pediatr 161 (2004) 80-84
7. Oxman M.N., and Levin M.J. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis 197 Suppl 2 (2008) S228-S236
8. Miller E. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4 (1993) 222-230
9. Edmunds W.J., Brisson M., and Rose J.D. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19 (2001) 3076-3090
10. Gauthier A., Breuer J., Carrington D., Martin M., and Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 137 (2009) 38-47
11. Mehta S.K., Tyring S.K., Gilden D.H., Cohrs R.J., Leal M.J., Castro V.A., et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 197 (2008) 654-657
12. Sengupta N., Taha Y., Scott F.T., Leedham-Green M.E., Quinlivan M., and Breuer J. Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster. J Infect Dis 196 (2007) 1014-1020
13. Loparev V.N., Rubtcova E.N., Bostik V., Govil D., Birch C.J., Druce J.D., et al. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J Virol 81 (2007) 12758-12765
14. Peters G.A., Tyler S.D., Grose C., Severini A., Gray M.J., Upton C., et al. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol 80 (2006) 9850-9860
15. Norberg P., Liljeqvist J.A., Bergström T., Sammons S., Schmid D.S., and Loparev V.N. Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol 80 (2006) 9569-9576
16. Muir W.B., Nichols R., and Breuer J. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol 76 (2002) 1971-1979
17. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., and Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76 (2002) 11447-11459
18. Quinlivan M., Sengupta N., and Breuer J. A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus. J Clin Virol 44 (2009) 66-69
19. Taha Y., Scott F.T., Parker S.P., Syndercombe Court D., Quinlivan M.L., and Breuer J. Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual. Clin Infect Dis 43 (2006) 1301-1303
20. Quinlivan M., Hawrami K., Barrett-Muir W., Aaby P., Arvin A., Chow V.T., et al. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186 (2002) 888-894
21. Gershon A., and Silverstein S. Varicella zoster virus. In: Richman D., Whitley R., and Hayden F. (Eds). Clinical Virology. 3rd Edition (2009), ASM Press, Washington, DC 451-473
22. Ku C.C., Besser J., Abendroth A., Grose C., and Arvin A.M. Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 79 (2005) 2651-2658
23. Sartori A. A review of the varicella vaccine in immunocompromised individuals. Int J Inf Dis 8 (2004) 259-270
24. Abendroth A., and Arvin A. Immune evasion mechanisms of varicella-zoster virus. Arch Virol Suppl 17 (2001) 99-107
25. Abendroth A., and Arvin A. Varicella-zoster virus immune evasion. Immunol Rev 168 (1999) 143-156
26. Weingberg J. Herpes zoster: Epidemiology, natural history, and common complications. J Am Acad Dermatol 57 (2007) S130-S135
27. Arvin A.M., Moffat J.F., and Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res 46 (1996) 263-309
28. Gershon A. Chickenpox, measles, and mumps. In: Remington J., Klein J., Wilson C., and Baker C. (Eds). Infections of the Fetus and Newborn Infant (2006), Saunders, Philadelphia 693-737
29. Kennedy P. Varicella-zoster virus latency in human ganglia. Rev Med Virol 12 (2002) 327-334
30. Arvin A.M., Pollard R.B., Rasmussen L.E., and Merigan T.C. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest 65 (1980) 869-878
31. Hata A., Asanuma H., Rinki M., Sharp M., Wong R.M., Blume K., et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347 (2002) 26-34
32. Onozawa M., Hashino S., Takahata M., Fujisawa F., Kawamura T., Nakagawa M., et al. Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. J Clin Microbiol 44 (2006) 4441-4443
33. Burke B.L., Steele R.W., Beard O.W., Wood J.S., Cain T.D., and Marmer D.J. Immune responses to varicella-zoster in the aged. Arch Intern Med 142 (1982) 291-293
34. Gershon A.A., Chen J., and Gershon M.D. A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis 197 Suppl 2 (2008) S61-S65
35. Chen J, Wan S, Bischoff S, Silverstein SJ, Gershon A, Gershon MD. Latent, lytic, and reactivating infection of human and guinea pig enteric neurons by varicella zoster virus. 28th Annual Herpesvirus Workshop; July 26-31, 2003; Madison, WI. Abstract 8.01.
36. Schmader K., George L.K., Burchett B.M., Peiper C.F., and Hamilton J.D. Racial differences in the occurrence of herpes zoster. J Infect Dis 171 (1995) 701-704
37. Schmader K., George L.K., Burchett B.M., Hamilton J.D., and Pieper C.F. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 46 (1998) 973-977
38. Schmader K., Studenski S., MacMillan J., Grufferman S., and Cohen H.J. Are stressful life events risk factors for herpes zoster?. J Am Geriatr Soc 38 (1990) 1188-1194
39. Schmader K., George L.K., Burchett B.M., and Pieper C.F. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 178 Suppl 1 (1998) S67-S70
40. Thomas S.L., and Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 4 (2004) 26-33
41. Heymann A.D., Chodick G., Karpati T., Kamer L., Kremer E., Green M.S., et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 36 (2008) 226-230
42. Hicks L.D., Cook-Norris R.H., Mendoza N., Madkan V., Arora A., and Tyring S.K. Family history as a risk factor for herpes zoster: a case-control study. Arch Dermatol 144 (2008) 603-608
43. Sato-Takeda M., Ihn H., Ohashi J., Tsuchiya N., Satake M., Arita H., et al. The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain 110 (2004) 329-336
44. Haanpää M., Nurmikko T., and Hurme M. Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster. Scand J Infect Dis 34 (2002) 112-114
45. Donahue J.G., Choo P.W., Manson J.E., and Platt R. The incidence of herpes zoster. Arch Intern Med 155 (1995) 1605-1609
46. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., and Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82 (2007) 1341-1349
47. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., and Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 20 (2005) 748-753
48. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 (2001) 305-314
49. Volpi A. Severe complications of herpes zoster. Herpes 14 Suppl 2 (2007) 35-39
50. Opstelten W., and Zaal M.J. Managing ophthalmic herpes zoster in primary care. BMJ 331 7509 (2005) 147-151
51. Gebo K.A., Fleishman J.A., and Moore R.D. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr 40 (2005) 609-616
52. Kost R.G., and Straus S.E. Postherpetic neuralgia: pathogenesis, treatment, and prevention. N Engl J Med 335 (1996) 32-42